Nouveauté

EMCDDA framework and practical guidance for naming cathinones

B. PULVER ; S. FISCHMANN ; A. GALLEGOS ; R. CHRISTIE | 2024
Dans Drug Testing and Analysis (Vol.16, n°12, December 2024) Article : Périodique

Cathinones are often sold as "legal" alternatives to controlled stimulants such as amphetamine, MDMA and cocaine. Cathinones are the second largest group of new psychoactive substances (NPS), with close to 170 monitored by the European Monitorin[...]

Plus d'info

Ajouter à la sélection

Lien externe

EMCDDA framework and practical guidance for naming synthetic cannabinoids

B. PULVER ; S. FISCHMANN ; A. GALLEGOS ; R. CHRISTIE | 2023
Dans Drug Testing and Analysis (Vol.15, n°3, March 2023) Article : Périodique

Synthetic cannabinoids (SCs), often sold as "legal" replacements for cannabis, are the largest group of new psychoactive substances monitored by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Currently, close to 240 struct[...]

Plus d'info

Ajouter à la sélection

Lien externe